Esperion Therapeutics
ESPR
#7422
Rank
HK$2.77 B
Marketcap
HK$14.10
Share price
-4.23%
Change (1 day)
-16.82%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -HK$0.23 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are HK$0.29 Billion. In 2023 the company made an earning of -HK$1.18 Billion, an increase over its 2022 earnings that were of -HK$1.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.23 Billion-80.89%
2023 -HK$1.18 Billion-15.03%
2022 -HK$1.38 Billion-20.61%
2021 -HK$1.74 Billion84.28%
2020 -HK$0.95 Billion35.75%
2019 -HK$0.7 Billion-55.71%
2018 -HK$1.57 Billion19.57%
2017 -HK$1.32 Billion125.39%
2016 -HK$0.59 Billion51.43%
2015 -HK$0.39 Billion36.45%
2014 -HK$0.29 Billion43.55%
2013 -HK$0.2 Billion145.26%
2012 -HK$79.91 Million
2002 -HK$0.23 Billion-7.81%
2001 -HK$0.25 Billion15.03%
2000 -HK$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$3.87 Billion 1,617.94%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.05 B-1,455.21%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$54.10 B-24,136.70%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$38.72 B-17,304.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.54 Billion 136.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.69 Billion 649.15%๐Ÿ‡บ๐Ÿ‡ธ USA